BEXTRA PULLED FROM THE MARKET

April 7, 2005: The FDA asked Pfizer to remove Bextra from the U.S. market stating that Bextra's risks outweigh its benefits. Bextra has been found to be associated with heart attacks, strokes, and other cardiovascular problems.

Background:

Bextra is a Cox-2 Inhibitor drug, and is in the same drug family as Vioxx and Celebrex. People that have been prescribed Bextra have experienced a higher number of heart attacks, strokes and other cardiovascular problems. Bextra is a COX-2 inhibitor, marketed by Pharmacia Corporation and Pfizer Inc. in the United States. The drug is prescribed for the treatment of osteoarthritis, adult rheumatoid arthritis, and the pain associated with menstrual cramping.

Where can I find additional information?

What you can do:

If you have experienced any serious side effects associated with your use of Bextra, we urge you to see your doctor. If you or a member of your family suffered severe reactions after the use of Bextra, it may be important to contact an attorney who can help you protect your potential legal claim. If you would like more information, or would just like to talk with a lawyer experienced in this litigation, please call attorney Ron Goldser at 1.800.755.0098 for a free consultation or click here to send an email.